CTOs on the Move

Heartland Dental

www.heartland.com

 
As a leading DSO, Heartland Dental provides supported dentists, hygienists, and non-clinical team members with world-class non-clinical administrative support to help them achieve sustainable professional and personal growth. What started from the entrepreneurial spirit of Rick Workman, DMD, with a single dental practice, has evolved into supporting over 2,700 dentists in over 1,700 dental offices across 38 states. Heartland Dental is not your typical Dental Support Organization. Its legacy of being built by a dentist, for dentists along with its doctor-led culture and business model enables supported doctors to be the leaders of their practice, working with their teams to ...
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.heartland.com
  • 1200 Network Centre Drive
    Effingham, IL USA 62401
  • Phone: 217.540.5100

Executives

Name Title Contact Details

Similar Companies

AccelBeam Synthesis

AccelBeam Synthesis, Inc. is a Garnet Valley, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TrueCare

TrueCare is a healthcare provider that offers medical, dental, women’s health services, mental/behavioral health services, pharmacy and chiropractic care in San Diego and Riverside Counties.

New Jersey Organ and Tissue

New Jersey Organ and Tissue is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New Jersey Organ and Tissue is based in New Providence, NJ. You can find more information on New Jersey Organ and Tissue at www.sharenj.org

Assil Eye Institute

Assil Eye Institute is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

StemCells

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.